Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WUCT aggregates regulatory documents tied to ETRACS Whitney US Critical Technologies ETNs issued by UBS AG, a foreign private issuer. The core filings here are Forms 6-K, which provide interim financial and legal updates that are incorporated by reference into UBS AG’s Form F-3 registration statement for securities offerings.
In these Form 6-K reports, UBS AG discloses consolidated capitalization in US dollars under IFRS Accounting Standards, detailing short-term and long-term debt issued by UBS AG and its subsidiaries, funding from UBS Group AG, equity attributable to shareholders and non-controlling interests, and total capitalization. Such information helps investors understand the broader balance sheet context of the issuer behind the WUCT-linked ETNs.
The filings also explain how specific 6-K reports are incorporated into UBS AG’s Form F-3 registration statement and any outstanding prospectuses or offering circulars that reference those 6-Ks. This structure means that updates filed on Form 6-K become part of the official documentation for securities, including the ETRACS Whitney US Critical Technologies ETNs associated with WUCT.
Another Form 6-K on this page consists of the opinion of Homburger AG, acting as special Swiss counsel to UBS AG, which is filed as an exhibit to the Form F-3 registration statement and replaces a prior opinion. This highlights the role of legal opinions in UBS AG’s securities registration process.
On Stock Titan, users can access these filings in one place, with AI-powered tools available to summarize key sections, highlight important capitalization and legal disclosures, and help interpret how each new Form 6-K or related document fits into UBS AG’s overall reporting framework for the WUCT-linked ETNs.
Offering overview: UBS AG is marketing unsecured, unsubordinated Trigger Autocallable Contingent Yield Notes linked to the common stock of Palantir Technologies Inc. The Notes are expected to price on 26 Jun 2025, settle on 30 Jun 2025 and mature on or about 30 Jun 2026, unless automatically called earlier.
Key terms:
- Issue price: $10 per Note; minimum purchase 100 Notes ($1,000).
- Contingent coupon: 17.40 %–19.18 % per annum, paid bimonthly only if Palantir’s closing price on the relevant observation date is ≥ the coupon barrier (60 % of the initial level).
- Automatic call: If Palantir’s price on any observation date prior to final valuation is ≥ the initial level, UBS redeems at par plus the due coupon and the transaction terminates.
- Downside protection: At maturity, if not previously called and Palantir’s final price is ≥ the downside threshold (50 % of the initial level), investors receive par; otherwise repayment is reduced one-for-one with the underlying decline, potentially to $0.
- Estimated initial value: $9.54–$9.79, reflecting underwriting discount ($0.125 per Note) and UBS’s internal funding spread.
- Distribution: Notes will not be listed on any exchange; secondary trading (if any) will be at prevailing market prices and may be limited.
Principal risks highlighted by the issuer:
- Market risk identical to holding Palantir below the 50 % downside threshold.
- No assurance of any coupon payments.
- Credit risk of UBS AG; the Notes are purely unsecured obligations.
- Liquidity risk due to absence of an exchange listing and the T+2 initial settlement.
Investor profile: Suitable only for investors who understand structured products, can tolerate a total loss of principal and seek enhanced income in exchange for equity downside risk and issuer credit exposure.